Komipharm International Co., Ltd. (KOSDAQ:A041960) announces a share repurchase program. Under the program, the company will repurchase up to 146,842 shares pursuant to a contract with KB Securities. The purpose of the program is to improve shareholder value and to stabilize stock price.

The program will expire on December 23, 2022. As of September 22, 2022, the company had 0 shares in treasury within scope available for dividend and had 298,437 shares in treasury through other repurchase.